Drug Type Proteolysis-targeting chimeras |
Synonyms BTX-1341 |
Target |
Mechanism CDK7 inhibitors(Cyclin-dependent kinase 7 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Preclinical | US | 25 Mar 2022 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Preclinical | US | 25 Mar 2022 |